重组人 Blood Group Kell Antigen 蛋白 (GST tag N-Terminus)
Recombinant Human Blood Group Kell Antigen protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human Blood Group Kell Antigen protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 732 aa range, expressed in Wheat germ, suitable for SDS-PAGE, ELISA, WB.
查看别名
CD238, Kell blood group glycoprotein, KEL
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human Blood Group Kell Antigen protein (GST tag N-Terminus) (AB116891)
12.5% SDS-PAGE showing ab116891 at approximately 106.59kDa stained with Coomassie Blue.
反应性数据
序列信息
性能和储存信息
形式
纯化工艺
运输条件
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Kell protein facilitates the degradation of endothelin precursors. It belongs to the neprilysin (M13) family of zinc endopeptidases playing a critical part in modulating vasoactive peptides. Normally the Kell protein forms a complex with another protein called XK an integral membrane protein. When properly functioning this Kell-XK complex maintains RBC integrity and membrane flexibility essential for normal cellular operations and lifespan.
Pathways
The Kell antigen influences pathways involved in cardiovascular regulation and cellular movement. It has connections with the vasoregulatory pathway where it interacts with endothelins. The breakdown of endothelin precursors by Kell reduces the levels of these potent vasoconstrictors. The protein also has an indirect association with members of the endothelin-converting enzyme family which further processes these peptides into active forms.
常规信息
功能
Zinc endopeptidase with endothelin-3-converting enzyme activity. Cleaves EDN1, EDN2 and EDN3, with a marked preference for EDN3.
序列相似性
Belongs to the peptidase M13 family.
翻译后修饰
N-glycosylated.
靶点信息
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com